Diane West, MD
Urology · Arlington, TXNPI 1861488256
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.9% of the total across 96 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $763 and has fallen 75.6% since, to $186 in 2025. That places this record below the midpoint for urology clinicians in TX, where the typical reported total is $3,394.
Across 96 payments — averaging $29.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$394
- Boston Scientific$293
- Axonics, Inc.$264
- AbbVie$228
- Kerecis Limited$224
- Agiliti Surgical, Inc.$161
- plus $1K from 22 others
What the payments were for
- Grants$1144%
- Food & beverage$2,68996%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 21 | $394 |
| Boston Scientific | 5 | $293 |
| Axonics, Inc. | 3 | $264 |
| AbbVie(2 entities) | 9 | $228 |
| Kerecis Limited | 2 | $224 |
| Agiliti Surgical, Inc. | 2 | $161 |
| Johnson & Johnson | 6 | $130 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $119 |
| Dendreon Pharmaceuticals LLC | 6 | $111 |
| Olympus America Inc. | 5 | $105 |
| Ferring Pharmaceuticals Inc. | 1 | $98 |
| Myovant Sciences Inc. | 5 | $93 |
| Urogen Pharma, Inc. | 3 | $77 |
| Blue Earth Diagnostics | 2 | $74 |
| Bayer | 3 | $57 |
| Innovation Technologies Inc | 1 | $46 |
| Tolmar Pharmaceuticals, Inc. | 3 | $46 |
| Endo Pharmaceuticals Inc. | 3 | $45 |
| Urovant Sciences Inc | 2 | $42 |
| Sanofi | 2 | $37 |
| Sun Pharmaceutical Industries Inc. | 2 | $33 |
| Merck | 1 | $24 |
| Neotract Inc. | 1 | $19 |
| Travere Therapeutics, Inc. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $16 |
| Foundation Medicine, Inc. | 1 | $15 |
| Antares Pharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,803 in reported general payments places this provider in the 40th percentile of 878 urology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Arlington
- James VestalArlington$290K
- Andrew SunArlington$280K
- Harrison AbrahamsArlington$136K
- Andrew von EschenbachMontgomery$3.2M
- Brian MazzarellaLakeway$1.2M
- Arun RaiHouston$920K
- Allen MoreyDallas$914K
- Donald GriffithHouston$732K
- Michael TrotterAustin$590K
- Vitaly MargulisDallas$555K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.